Den norske Eterfabrikk Overview

  • Founded
  • 1900

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Den norske Eterfabrikk General Information


Operator of a pharmaceutical company. The company is engaged in developing and marketing of prescription drugs, OTC, cosmetics and chemicals. Its products include Methadone (substitution), STOP24 (sweat treatment), Malation (lice treatment), plaster remover, wart funds and ether.

Contact Information

Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • PO Box 10 Bøler
  • 0620 Oslo
  • Norway

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Den norske Eterfabrikk Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Den norske Eterfabrikk‘s full profile, request access.

Request a free trial

Den norske Eterfabrikk Executive Team (1)

Name Title Board Seat Contact Info
Kim Wedum Managing Director
To view Den norske Eterfabrikk’s complete executive team members history, request access »